AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 88 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $92,944 | -47.5% | 320,498 | -18.6% | 0.00% | -100.0% |
Q4 2022 | $177,098 | +228.0% | 393,638 | +280.0% | 0.00% | – |
Q3 2022 | $54,000 | -66.2% | 103,589 | -67.2% | 0.00% | -100.0% |
Q2 2022 | $160,000 | -67.9% | 315,840 | +45.8% | 0.00% | 0.0% |
Q1 2022 | $498,000 | +62.7% | 216,601 | +235.8% | 0.00% | 0.0% |
Q4 2021 | $306,000 | +111.0% | 64,511 | +251.9% | 0.00% | – |
Q1 2021 | $145,000 | -71.3% | 18,332 | -71.5% | 0.00% | -100.0% |
Q4 2020 | $506,000 | -49.3% | 64,263 | -54.3% | 0.00% | -75.0% |
Q3 2020 | $998,000 | +31.0% | 140,772 | +70.8% | 0.00% | 0.0% |
Q2 2020 | $762,000 | +361.8% | 82,427 | +132.7% | 0.00% | +300.0% |
Q1 2020 | $165,000 | -56.5% | 35,421 | -28.6% | 0.00% | 0.0% |
Q4 2019 | $379,000 | +11.8% | 49,622 | +0.3% | 0.00% | 0.0% |
Q2 2019 | $339,000 | +34.5% | 49,458 | +87.5% | 0.00% | 0.0% |
Q3 2018 | $252,000 | +98.4% | 26,382 | +119.4% | 0.00% | – |
Q2 2018 | $127,000 | – | 12,026 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Yu Fan | 112,044 | $50,420 | 0.68% |
Aisling Capital Management LP | 1,691,151 | $761,018 | 0.50% |
Sio Capital Management, LLC | 3,004,959 | $1,351,931 | 0.50% |
Bain Capital Life Sciences Investors, LLC | 5,347,689 | $2,406 | 0.27% |
Ghost Tree Capital, LLC | 800,000 | $360,000 | 0.15% |
Nantahala Capital Management | 4,611,302 | $2,074,625 | 0.13% |
Samsara BioCapital, LLC | 883,720 | $397,586 | 0.09% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,059,894 | $1,826,546 | 0.08% |
SPHERA FUNDS MANAGEMENT LTD. | 440,837 | $198,333 | 0.04% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $111 | 0.04% |